<DOC>
	<DOCNO>NCT01439243</DOCNO>
	<brief_summary>The objective study compare rate extent absorption donepezil 10 mg tablet ( test ) versus AriceptÂ® ( reference ) , administer 1 x 10 mg tablet feed condition .</brief_summary>
	<brief_title>Donepezil 10 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Method : FDA Bioequivalence Statistical Methods</detailed_description>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Male female , nonsmoker , &gt; 18 &lt; 55 year age . Capable consent . BMI &gt; 19.0 &lt; 27.0 . Good state health ( clinically significant deviation normal clinical result laboratory test finding ) . Absence inclusion criterion . Clinically significant illness ( include hyperglycemia , form diabetes glucose intolerance , congestive heart failure , hepatitis , hypotensive episode ) surgery within 8 week prior dose . All clinically significant abnormality abnormal laboratory test result find medical screening . Any reason , opinion Medical SubInvestigator , would prevent subject participate study . Positive test hepatitis B. hepatitis C , HIV screen . ECG abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 95 140 mmHg , diastolic blood pressure low 50 90 mmHg , heart rate less 50 100 bpm ) screening . History significant alcohol abuse drug abuse within 1 year prior screen visit . Regular use alcohol within 12 month prior screen visit ( 14 unit alcohol per week [ 1 unit = 150 mL wine , 360 mL beer , 45 mL 40 % alcohol ] ) positive alcohol breath test screening . Use soft drug ( marijuana ) within 3 month prior screen visit hard drug ( cocaine , phencyclidine , crack ) within 1 year prior screen visit positive urine drug screen screen . History allergic reaction donepezil , piperidine derivative , relate drug . Use drug know induce inhibit hepatic drug metabolism ( example inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , omeprazole ; examples inhibitor : antidepressant , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) within 30 day prior administration study medication . Use investigational drug participation investigational study within 30 day prior dose . Clinically significant history presence gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) , unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug . Any clinically significant history presence neurological , endocrinal , cardiovascular , pulmonary , hematological , immunologic , psychiatric , metabolic disease . Use prescription medication within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption hormonal contraceptive . Difficulty swallow study medication . Use tobacco product 3 month precede screen visit . Any food allergy , intolerance , restriction , special diet , opinion Medical SubInvestigator , could contraindicate subject 's participation study . A depot injection implant drug ( hormonal contraceptive ) within 3 month prior administration study medication . Donation plasma ( 500 mL ) within 7 day prior drug administration . Donation loss whole blood ( exclude volume blood drawn screening procedure study ) prior administration study medication follow : 50 mL 499 mL whole blood within 30 day , 499 mL whole blood within 56 day prior drug administration . Positive urine pregnancy test screening . Breastfeeding subject . Female subject childbearing potential unprotected sexual intercourse nonsterile male partner ( i.e . male sterilized vasectomy least 6 month ) within 14 day prior study drug administration . History asthma obstructive pulmonary disease . History ulcer disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
	<keyword>Donepezil</keyword>
</DOC>